NM_003954.5:c.1009C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_003954.5(MAP3K14):c.1009C>T(p.Leu337Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000665 in 1,611,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00068 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 0 hom. )
Consequence
MAP3K14
NM_003954.5 synonymous
NM_003954.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.987
Publications
0 publications found
Genes affected
MAP3K14 (HGNC:6853): (mitogen-activated protein kinase kinase kinase 14) This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]
MAP3K14 Gene-Disease associations (from GenCC):
- NIK deficiencyInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 17-45286574-G-A is Benign according to our data. Variant chr17-45286574-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 544335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.987 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAP3K14 | NM_003954.5 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 5 of 16 | ENST00000344686.8 | NP_003945.2 | |
| MAP3K14 | XM_047436997.1 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 5 of 15 | XP_047292953.1 | ||
| MAP3K14 | XM_047436998.1 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 6 of 16 | XP_047292954.1 | ||
| MAP3K14 | XM_011525441.3 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 6 of 17 | XP_011523743.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MAP3K14 | ENST00000344686.8 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 5 of 16 | 1 | NM_003954.5 | ENSP00000478552.1 | ||
| MAP3K14 | ENST00000376926.8 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 4 of 15 | 1 | ENSP00000482657.1 | |||
| MAP3K14 | ENST00000617331.3 | c.1009C>T | p.Leu337Leu | synonymous_variant | Exon 6 of 17 | 5 | ENSP00000480974.3 |
Frequencies
GnomAD3 genomes AF: 0.000683 AC: 104AN: 152194Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
104
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000476 AC: 116AN: 243592 AF XY: 0.000423 show subpopulations
GnomAD2 exomes
AF:
AC:
116
AN:
243592
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000663 AC: 967AN: 1459036Hom.: 0 Cov.: 32 AF XY: 0.000589 AC XY: 427AN XY: 725496 show subpopulations
GnomAD4 exome
AF:
AC:
967
AN:
1459036
Hom.:
Cov.:
32
AF XY:
AC XY:
427
AN XY:
725496
show subpopulations
African (AFR)
AF:
AC:
6
AN:
33420
American (AMR)
AF:
AC:
65
AN:
44282
Ashkenazi Jewish (ASJ)
AF:
AC:
47
AN:
25912
East Asian (EAS)
AF:
AC:
0
AN:
39662
South Asian (SAS)
AF:
AC:
1
AN:
85562
European-Finnish (FIN)
AF:
AC:
0
AN:
53210
Middle Eastern (MID)
AF:
AC:
1
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
786
AN:
1110928
Other (OTH)
AF:
AC:
61
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
63
126
189
252
315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000683 AC: 104AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
104
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
12
AN:
41552
American (AMR)
AF:
AC:
34
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44
AN:
68032
Other (OTH)
AF:
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MAP3K14: BP4, BP7 -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
NIK deficiency Benign:1
Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.